SCHEMBL29958798

SCHEMBL29958798

NC(=O)C1(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2csc3ccccc23)NC(=O)C2CCCNC2)CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29436746 1.00 GHSR (0.46) GHSR
SCHEMBL17513917 1.00 GHSR (0.46) GHSR
SCHEMBL19586388 1.00 GHSR (0.46) GHSR
Relamorelin SCHEMBL19606783 0.93 GHSR (0.54) GHSR
Relamorelin SCHEMBL19203687 0.93 GHSR (0.54) GHSR
Relamorelin SCHEMBL19606784 0.93 GHSR (0.54) GHSR
SCHEMBL18488500 0.86 GHSR (0.57) GHSR
SCHEMBL20591195 0.86 GHSR (0.54) GHSR
SCHEMBL18488501 0.84 GHSR (0.54) GHSR
SCHEMBL19203560 0.81 MEN1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226116-A1 GHRELIN TREATMENT OF BRAIN DYSFUNCTION DUE TO VIRAL INFECTION OXEIA BIOPHARMACEUTICALS, INC. (US) 2022-10-27 WO disclosed